30 results on '"Hollande, Clémence"'
Search Results
2. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors
3. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
4. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
5. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
6. Implication du pharmacien hospitalier dans le parcours des patients sous anticancéreux oraux en oncologie digestive
7. Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study.
8. THU-492 Prognostic significance of liver decompensation, liver function and portal hypertension in cirrhotic patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab
9. OS-077 Added value of a combination of positron emission tomography with 18F-FDG and 18 F-Fluorocholine for staging optimization and treatment modification in patients with hepatocellular carcinoma: the prospective multicentric PET HCC01 study
10. Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma.
11. Reply to: “Focus on the decisions to forego life-sustaining therapies during ICU stay of patients with cirrhosis and COVID-19: A case control study from the prospective COVID-ICU database”
12. Factors and Mechanisms Involved in Acquired Developmental Defects of Enamel: A Scoping Review
13. Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
14. Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
15. Reply to: “Association of chronic liver disease with the prognosis of COVID-19 patients”
16. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020
17. Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”
18. Safety of sitagliptin in treatment of hepatocellular carcinoma in chronic liver disease patients
19. Treatment of hepatitis C virus infection
20. Primary biliary cholangitis and systemic sclerosis (Reynolds syndrome): A case–control study
21. Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours
22. LI-RADS v2018 major criteria: Do hepatocellular carcinomas in non-alcoholic steatohepatitis differ from those in virus-induced chronic liver disease on MRI?
23. THU-122 - Efficacy and safety of atezolizumab and bevacizumab in the real-world treatment of Child Pugh B patients with advanced hepatocellular carcinoma
24. Micro‐elimination of hepatitis C virus
25. Editorial: reciprocal interaction between HCV direct-acting anti-virals (DAA) and hepatocellular carcinoma (HCC)-a negative impact of HCC on sustained virologic response not of DAA on HCC
26. FRI-470-External beam radiotherapy as an effective and safe treatment in all stages of hepatocellular carcinoma with cirrhotic liver disease : A single institution experience
27. Role of dipeptidyl peptidase-4 in the regulation of leucocyte trafficking in hepatocellular carcinoma
28. PS-204-The relationship between FIB-4 progression and liver outcome among patients with type 2 diabetes mellitus: A population based hospital study
29. Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus
30. Necrotizing pancreatitis complicated by oesophageal haemorrhage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.